Addendum to MOH Circular No. 53/2025 Introduction of Familial Hypercholesterolaemia (FH) Genetic Testing Service

MOH Circular No. 89/2025

Availability of JN.1 NOVAVAX/NUVAXOVID COVID-19 Vaccine under National Vaccination Programme for 2025/2026

MOH Circular No: 88/2025

Updated Recommendations on Hepatitis B vaccination and Subsidy Eligibility

MOH Circular No. 85/2025, MH 34:26/2

Use of National Electronic Health Record (NEHR) Diagnosis Data for Calculation of Screening Eligibility for Healthier SG Screening

FAQs on Use of NEHR for CVD Screening Eligibility

HSG GP Guide on Selection of Screening Date for Screening-Related ASF Payments

HSG

Removal of expiring Healthier SG visual materials

[eDM] Submission of Healthier SG Care Reporting 2025

HSG

Medical Health Requirements for Prospective Haj Pilgrims

MOH Circular No. 66/2025, MUI-3606-00-14, MH 70:52/18

Familial Hypercholesterolaemia (FH) FAQ

COVID-19 Vaccination Recommendations for 2025/2026 and the updated LP.8.1 COVID-19 Vaccine

MOH Circular No. 67/2025

Update on the Temporary Supply Disruption of Sitagliptin 25mg and 50mg Tablets with effect from 15 Oct 2025 due to Discontinuation of the Products by the Vendor

HSG

Change in Pre-subsidy Price Caps, Subvention and Patient Co-payment Caps for Measles, Mumps and Rubella Vaccination

MH 6:02/10-3, MOH FCM No. 48/2025

National Childhood Immunisation Schedule (NCIS) [with updates to Annex A caa 20 Dec 2022]

MOH Circular No. 180/2020, MOH FCM No. 48/2025

National Adult Immunisation Schedule (NAIS) [with updates to Annex A, B and C caa 21 Aug 2025]

MOH Circular No. 51/2025, MOH FCM No. 48/2025

Revisions to the Onboarding Criteria of Mental Health General Practitioner Partnership (MHGPP)

MOH Circular No. 59/2025

Maintaining Vigilance against Influenza Virus in Singapore

Update on the permanent supply disruption of dipyridamole 25mg tablet due to discontinuation of the product by the vendor

HSG

Update on Upcoming Supply Disruption of Sitagliptin 100mg Tablet and Summary of Change to the Healthier SG Medication List

HSG

Updated Circular on Introduction of Familial Hypercholesterolaemia Genetic Testing Service

MOH Cir No 53/2025

Update on Ebola Virus Disease Situation in Africa

[Annex A] Update on Ebola Virus Disease Situation in Africa

MOH Circular No. 36/2019

Reclassification of Etomidate as a Controlled Drug (CD) Under the Misuse of Drugs Act (MDA)

MOH Circular No. 54/2025

Guidelines for disability verification using the disability verification form (Physical Disability)

MOH Circular No. 46/2025